Table of Contents

1. Report Overview
1.1 Global Infectious Disease Diagnostics Market Overview
1.2 Global Infectious Disease Diagnostics Market Segmentation
1.3 Infectious Disease Diagnostics Report Structure
1.4 Why You Should Read This Report
1.5 How This Report Delivers
1.6 Key Questions Answered by This Analytical Report
1.7 Who is This Report For?
1.8 Methodology
1.8.1 Primary Research
1.8.2 Secondary Research
1.8.3 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)

2. The Global Infectious Disease Diagnostics Market (Disease Type) 2017-2027
2.1 An Introduction to Major Types of Infectious Diseases
2.2 HIV/AIDS
2.2.1 Antibody tests
2.2.2 Combination tests (Antigen/Antibody tests)
2.2.3 Nucleic Acid Tests (NATS)
2.3 Hepatitis
2.3.1 Enzyme test
2.3.2 Viral antibodies
2.4 Tuberculosis
2.5 Malaria
2.6 Chlamydia

3. The Global Infectious Disease Diagnostics Market (Technique) 2017-2027
3.1 An introduction to various types of techniques
3.2 Immunoassay
3.3 Molecular Diagnostics
3.4 Point of care/ rapid diagnosis
3.5 Microbiology
3.5.1 Culture
3.5.2 Microbial identification
3.6 Market Shares by Segment, 2017 and 2027
3.7 World Infectious Disease Diagnostics Market: Forecast by technique 2017-2027

4. The Global Infectious Disease Diagnostics Market (End User) 2017-2027
4.1 An introduction to end users
4.2 Hospitals
4.3 Clinical Laboratories
4.4 Others
4.5 Market Shares by end users, 2017-2027

5. The Global Infectious Disease Diagnostics Market (Geography) 2017-2027
5.1 An Introduction to the Infectious Disease Diagnostics Market by geography
5.2 United States Infectious Disease Diagnostics Market
5.2.1 United States Infectious Disease Diagnostics Market: by disease type
5.2.2 United States Infectious Disease Diagnostics Market: by end user
5.3 EU-5 Infectious Disease Diagnostics Market
5.3.1 EU-5 Infectious Disease Diagnostics Market: by disease type
5.3.2 EU-5 Infectious Disease Diagnostics Market: by End User
5.3.3 EU-5 Infectious Disease Diagnostics Market: by Country
5.3.3.1 Germany
5.3.3.2 France
5.3.3.3 United Kingdom
5.3.3.4 Spain
5.3.3.5 Italy
5.4 Japan Infectious Disease Diagnostics Market
5.4.1 Japan Infectious Disease Diagnostics Market: by disease type
5.4.2 Japan Infectious Disease Diagnostics Market: by End User
5.5 BRIC Infectious Disease Diagnostics Market
5.5.1 BRIC Infectious Disease Diagnostics Market: by disease type
5.5.2 BRIC Infectious Disease Diagnostics Market: by End User
5.5.3 BRIC Infectious Disease Diagnostics Market: by country
5.5.3.1 Brazil
5.5.3.2 India
5.5.3.3 Russia
5.5.3.4 China

6. Leading Companies in Infectious Disease Diagnostics Market
6.1 Introduction
6.2 Abbott Laboratories
6.2.1.1 Business Overview
6.2.1.2 Recent Financials
6.2.1.3 Product Offerings
6.2.1.4 Recent developments
6.3 Becton, Dickinson and Company
6.3.1.1 Business Overview
6.3.1.2 Recent Financials
6.3.1.3 Product Offerings
6.3.1.4 Recent developments
6.4 Biomérieux
6.4.1.1 Business Overview
6.4.1.2 Recent Financials
6.4.1.3 Product Offerings
6.4.1.4 Recent developments
6.5 Bio-Rad Laboratories
6.5.1.1 Business Overview
6.5.1.2 Recent Financials
6.5.1.3 Product Offerings
6.5.1.4 Recent developments
6.6 Alere, Inc
6.6.1.1 Business Overview
6.6.1.2 Recent Financials
6.6.1.3 Product Offerings
6.6.1.4 Recent developments
6.7 Siemens Healthcare
6.7.1.1 Business Overview
6.7.1.2 Recent Financials
6.7.1.3 Product Offerings
6.7.1.4 Recent Developments
6.8 Roche Diagnostics
6.8.1.1 Business Overview
6.8.1.2 Recent Financials
6.8.1.3 Product Offerings
6.8.1.4 Recent Developments
6.9 Danaher Corporation
6.9.1.1 Business Overview
6.9.1.2 Recent Financials:
6.9.1.3 Product and Service Offerings
6.9.1.4 Recent developments
6.10 Thermo-Fisher Scientific, Inc.
6.10.1.1 Recent Financials
6.10.1.2 Product Offerings
6.10.1.3 Recent Developments
6.11 Other Players of Importance within the Global Infectious Disease Diagnostics Industry

7. Qualitative Analysis
7.1 Porter’s Five Forces Analysis
7.1.1 Bargaining Power of Buyers
7.1.2 Bargaining Power of Suppliers
7.1.3 Industry Rivalry
7.1.4 Threat of New Entrants
7.1.5 Threat of Substitutes

8. Conclusion and Recommendation
8.1 Key Take-Away
8.2 Conclusion

9. Glossary